ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates
MHRA Drug Safety Updates

 

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

MHRA Drug Safety Update March-2022-DSU-PDF.pdf

MHRA Drug Safety Update March-2022-DSU-PDF.pdf
Summary: Cladribine (Mavenclad): new advice to minimise risk of serious liver injury, Amiodarone (Cordarone X): reminder of risks of treatment and need for patient monitoring and supervision, Metformin in pregnancy: study shows no safety concerns, COVID-19 vaccines and medicines: updates for March 2022
File Size: 420KB
File Type: application/pdf
Created: 15 March 2022
Last Modified: 27 April 2022